Načítá se...
Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis
Abstract Background The role of neuromuscular blocking agents (NMBAs) in coronavirus disease 2019 (COVID-19) acute respiratory distress syndrome (ARDS) is not fully elucidated. Therefore, we aimed to investigate in COVID-19 patients with moderate-to-severe ARDS the impact of early use of NMBAs on 90...
Uloženo v:
Hlavní autoři: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
BMC
2022-05-01
|
Edice: | Critical Care |
Témata: | |
On-line přístup: | https://doi.org/10.1186/s13054-022-03983-5 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|